Enphase Energy Inc vs HCA Health Inc — how do they compare? Enphase Energy Inc trades at $32.81 (market cap $4.35B), while HCA Health Inc trades at $451.09 (market cap $96.35B). The key difference: HCA Health Inc is far larger — about 22.1× Enphase Energy Inc's market cap, and HCA Health Inc pays a 0.7% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and HCA Health Inc for 76 Days on average.
| ENPH | HCA | |
|---|---|---|
Market Cap | $4.35B | $96.35B |
Volume | 5,068,595 | 1,079,453 |
Sector | Energy | Health |
52-Week High | $72.33 | $545.13 |
52-Week Low | $26.12 | $361.32 |
Typical Hold Time | 72 Days | 76 Days |
Enterprise Value | $3.99B | $146.88B |
Dividend Yield | — | 0.7% |
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.91, down 1.76% amid bearish technical signals and mixed earnings performance. The stock faces headwinds from solar sector volatility but maintains solid fundamentals with 46.95% gross margins and positive cash flow. Recent developments include IQ Meter Collar utility approvals and solid-state transformer advancements for AI data centers, providing potential growth catalysts despite recent earnings misses.
The outlook remains cautious with analyst consensus at $42.90 offering 30% upside potential, though technical indicators suggest near-term pressure. Key risks include solar industry financing challenges and competitive threats, while institutional sentiment shows modest optimism with 42% buy ratings. The stock presents a growth opportunity for investors comfortable with sector volatility and execution risks.
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with net income of $6.78 billion, while valuation metrics like a P/E of 14.92 appear reasonable. The company announced a dividend of $0.78 and completed the acquisition of The College of Health Care Professions, signaling growth initiatives.
The outlook is positive, supported by analyst consensus with a $461.12 price target and 63% buy ratings, though risks include ongoing legal investigations and high debt levels. Earnings growth and operational efficiency remain key drivers for potential upside, but investors should monitor regulatory and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →